ISSN 1662-4009 (online)

ey0016.15-14 | (1) | ESPEYB16

15.14. Enteroendocrine cells switch hormone expression along the crypt-to-villus BMP signalling gradient

Beumer Joep , Artegiani Benedetta , Post Yorick , Reimann Frank , Gribble Fiona , Nguyen Thuc Nghi , Zeng Hongkui , Van den Born Maaike , Van Es Johan H , Clevers Hans

To read the full abstract: Nature Cell Biology 20,909–916 (2018)Produced by scattered Enteroendocrine cells (EECs)found along the length of the intestinal epithelium, gut hormones generate signals related to the rate of nutrient absorption, the composition of the luminal milieu and the integrity of the epithelial barrier. To study these rare cells, these authors combined the te...

ey0015.3-17 | Reviews | ESPEYB15

3.17 Diagnostic utility of molecular and imaging biomarkers in cytological indeterminate thyroid nodules

EJ de Koster , LF de Geus-Oei , OM Dekkers , I van Engen-van Grunsven , J Hamming , EPM Corssmit , H Morreau , A Schepers , J Smit , WJG Oyen , D Vriens

To read the full abstract: Endocr Rev 2018;39:154-191This extensive paper reviews current state of knowledge concerning possible diagnostic accuracy of all available biomarkers used for molecular diagnostics and in nuclear medicine for investigation of thyroid nodules of indeterminate cytology....

ey0020.3-7 | Advances in Clinical Practice | ESPEYB20

3.7. Prevalence of monogenic bone disorders in a Dutch cohort of atypical femur fracture patients

W Zhou , JG van Rooij , DM van de Laarschot , Z Zervou , H Bruggenwirth , NM Appelman-Dijkstra , PR Ebeling , S Demirdas , AJ Verkerk , MC Zillikens

In Brief: Prolonged bisphosphonate treatment is associated with atypical femoral fractures (AFF). However, AFFs also occur in bisphosphonate-naïve patients, so bisphosphonate is not a prerequisite for AFF. This study found a higher yield of (likely) pathogenic variants in AFF patients with a clinical suspicion of monogenic bone disorder, stressing the importance of careful clinical evaluation of patients who present with this condition.Commentary: A...

ey0020.7-1 | Gonadal Function and Fertility Issues in Childhood Cancer Survivors | ESPEYB20

7.1. Childhood cancer and hematological disorders negatively affect spermatogonial quantity at diagnosis: a retrospective study of a male fertility preservation cohort

I Masliukaite , E Ntemou , EAM Feijen , M van de Wetering , A Meissner , AT Soufan , S Repping , LMC Kremer , K Jahnukainen , E Goossens , AMM van Pelt

Brief summary: This multicentre retrospective cohort study evaluated testicular structure in 101 boys aged <14 years with solid tumors, CNS tumors, leukemia/lymphoma, or non-malignant hematological disorders, who were admitted for a fertility preservation programme between 2002 and 2018.The aim of the study was to clarify a possible role of the disease itself on the risk of infertility, independently of cancer therapies. Clinical data, testicular vol...

ey0018.4-8 | Growth Hormone Therapy: Safety | ESPEYB18

4.8. Longitudinal study on metabolic health in adults SGA during 5 years after GH with or without 2 years of GnRHa treatment

Goedegebuure Wesley J. , van der Steen Manouk , Kerkhof Gerthe F , Hokken-Koelega Anita CS

J Clin Endocrinol Metab, August 2020, 105(8):e2796–e2806. doi: 10.1210/clinem/dgaa287. PMID: 32436961The aim of this longitudinal study was to investigate the potential long-term adverse effects of combined GnRHa/GH treatment on metabolic and bone health in short SGA children. Reassuring data are found at 5 years after cessation of GH therapy.Children born small ...

ey0018.6-10 | Patient Related Outcomes | ESPEYB18

6.10. Participant- and Clinician-Reported Long-Term Outcomes After Surgery in Individuals with Complete Androgen Insensitivity Syndrome

Duranteau Lise , Rapp Marion , van de Grift Tim C , Hirschberg Angelica L

J Pediatr Adolesc Gynecol. 2021 Apr;34(2):168–175. doi:10.1016/j.jpag.2020.11.012. PMID: 33248216The authors report the long-term outcomes of 71 patients with Complete Androgen Insensitivity Syndrome (CAIS) in the multicentre cross-sectional dsd-LIFE study. Patients were included at 14 different sites in 6 countries in Europe. This is one of the largest long-term studies on CAIS and is of interest to clinicians who manage girls and women wi...

ey0018.6-15 | Longterm Effects of Hormonal Treatments in Gender Dysphoria | ESPEYB18

6.15. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty

MA van der Loos , I Hellinga , MC Vlot , DT Klink , M den Heijer , CM Wiepjes

J Bone Miner Res. 2021 May;36(5):931–941. doi: 10.1002/jbmr.4262. PMID: 33507568.This restrospective study of the Cohort of Gender Dysphoria investigated bone geometry parameters of 106 adolescent trans-women and 216 adolescent trans-men during early and late start of gonadotropin-releasing hormone agonist (GnRHa) and gender affirming hormone therapy (GAHT). Transgender youth who started tr...

ey0018.9-3 | Childhood cancer and thyroid disease | ESPEYB18

9.3. Presentation and outcome of subsequent thyroid cancer among childhood cancer survivors compared to sporadic thyroid cancer: a matched national study

SC Clement , CA Lebbink , MS Klein Hesselink , JC Teepen , TP Links , CM Ronckers , HM van Santen

Eur J Endocrinol. 2020; 183: 169–180. https://pubmed.ncbi.nlm.nih.gov/32449692/This retrospective study analyzed subsequent differentiated thyroid cancer (DTC) in in a group of CCS (n=31) matched with patients affected by sporadic DTC (n=93) to compare clinical presentation and outcomes. CCS with subsequent DTC were identified by two source populations: the DCOG-LATER cohort o...

ey0019.3-12 | Autoimmune Thyroid Disease | ESPEYB19

3.12. The 2022 European Thyroid Association guideline for the management of pediatric Graves' disease

CF Mooij , TD Cheetham , FA Verburg , A Eckstein , SH Pearce , J Leger , ASP van Trotsenburg

Eur Thyroid J. 2022 Jan 1;11(1):e210073. doi: 10.1530/ETJ-21-0073. PMID: 34981748The 2022 European Thyroid Association Guidelines for the management of Graves’ disease in the pediatric age group is an important document summarizing all aspects of the disease, ranging from diagnosis, medical treatment with its advantages and side effects, definitive treatment by thyroidectomy or radioiodine a...

ey0019.6-12 | Gender Incongruence: Growth and fertility in transgender girls | ESPEYB19

6.12. Trans girls grow tall: adult height is unaffected by GnRH analogue and estradiol treatment

LS Boogers , CM Wiepjes , DT Klink , I Hellinga , Trotsenburg ASP van , Heijer M den , SE Hannema

J Clin Endocrinol Metab. 2022 Jun 6:dgac349. PMID: 35666195, doi: 10.1210/clinem/dgac349. Brief Summary: This paper reports the adult height of 161 transgender girls (registered male at birth) from the Amsterdam Cohort of Gender Dysphoria. It finds no difference in adult height between use of standard and high estrogen doses. There is currently very little information on...